Literature DB >> 25242093

BRAF V600E mutation-specific immunohistochemistry is a rare finding in dendritic cell- and histiocyte-derived tumors.

Yuri Fedoriw1, Young S Kim, Jo-Anne Vergilio, Z Will Chen, Lawrence M Weiss, Dennis P O'Malley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25242093     DOI： 10.3109/10428194.2014.946028

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

1.  Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling.

Authors:  Xuejun Tian; Jie Xu; Christopher Fletcher; Jason L Hornick; David M Dorfman
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

2.  Potential clinical implications of BRAF mutations in histiocytic proliferations.

Authors:  Anna-Maria Bubolz; Stephanie E Weissinger; Albrecht Stenzinger; Annette Arndt; Konrad Steinestel; Silke Brüderlein; Holger Cario; Anneli Lubatschofski; Claudia Welke; Ioannis Anagnostopoulos; Thomas F E Barth; Ambros J Beer; Peter Möller; Martin Gottstein; Andreas Viardot; Jochen K Lennerz
Journal:  Oncotarget       Date:  2014-06-30

3.  Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016.

Authors:  Alexandar Tzankov; Markus Kremer; Roos Leguit; Attilio Orazi; Jon van der Walt; Umberto Gianelli; Konnie M Hebeda
Journal:  Ann Hematol       Date:  2018-08-06       Impact factor: 3.673
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.